- Home
- SBSW vs AGIO Comparison
SBSW vs AGIO Comparison
Compare SBSW & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBSW
- AGIO
- Stock Information
- Founded
- SBSW 2013
- AGIO 2007
- Country
- SBSW South Africa
- AGIO United States
- Employees
- SBSW N/A
- AGIO 386
- Industry
- SBSW Precious Metals
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- SBSW Basic Materials
- AGIO Health Care
- Exchange
- SBSW Nasdaq
- AGIO Nasdaq
- Market Cap
- SBSW 3.0B
- AGIO 2.4B
- IPO Year
- SBSW N/A
- AGIO 2013
- Fundamental
- Price
- SBSW $3.72
- AGIO $41.69
- Analyst Decision
- SBSW Hold
- AGIO Buy
- Analyst Count
- SBSW 4
- AGIO 7
- Target Price
- SBSW $4.98
- AGIO $56.33
- AVG Volume (30 Days)
- SBSW 4.7M
- AGIO 886.0K
- Earning Date
- SBSW 12-27-2024
- AGIO 10-31-2024
- Dividend Yield
- SBSW N/A
- AGIO N/A
- EPS Growth
- SBSW N/A
- AGIO N/A
- EPS
- SBSW N/A
- AGIO 11.80
- Revenue
- SBSW $5,933,684,244.00
- AGIO $32,871,000.00
- Revenue This Year
- SBSW N/A
- AGIO $33.38
- Revenue Next Year
- SBSW $5.67
- AGIO $163.06
- P/E Ratio
- SBSW N/A
- AGIO $3.53
- Revenue Growth
- SBSW N/A
- AGIO 36.79
- 52 Week Low
- SBSW $3.08
- AGIO $20.96
- 52 Week High
- SBSW $5.93
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- SBSW 38.24
- AGIO 35.05
- Support Level
- SBSW $3.81
- AGIO $37.20
- Resistance Level
- SBSW $4.38
- AGIO $44.46
- Average True Range (ATR)
- SBSW 0.14
- AGIO 3.88
- MACD
- SBSW -0.02
- AGIO -1.96
- Stochastic Oscillator
- SBSW 0.00
- AGIO 16.89
About SBSW D/B/A Sibanye-Stillwater Limited ADS
Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.